Press Release: ProPhase Labs Presentation at 4th Quarter Investor Summit Group |

GARDEN CITY, NY, Nov. 7, 2022 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotechnology company, today announced that it will participate in the Q4 Investor Summit Conference on November 14, 2022 in New York, New York, York will take place. Ted Karkus, CEO and Chairman of the Board of ProPhase Labs, will present on November 14, 2022 at 3:00 p.m. ET.

Around Prophase laboratories

ProPhase Labs, Inc. (Nasdaq: PRPH) (“ProPhase”) is a growth-oriented and diversified diagnostics, genomics and biotechnology company. The Company aims to leverage its CLIA laboratory services to provide whole genome sequencing and research directly to consumers while building a genomics database that can be used for further research. The company offers traditional CLIA molecular laboratory services, including COVID-19 testing. The Company also operates a state-of-the-art contract manufacturing subsidiary and offers the TK supplement line…